<?xml version="1.0" encoding="UTF-8"?>
<p>It can be concluded from this study that 
 <italic>M. charantia</italic> has a potential to ameliorate biochemical and histological changes in the liver of alloxan-induced diabetic Wistar rats. The amelioration of liver damage exhibited by the MLEMC was comparable to glibenclamide, the standard drug used in this study. In addition, this study revealed that 
 <italic>M. charantia</italic> possesses anti-apoptotic and anti-inflammatory potentials.
</p>
